彭晖, 杨纯正, 梁巍, 齐静, 黄牛, 郭宗儒. 吩噻嗪类化合物抑制肿瘤细胞多药耐药及蛋白激酶C活性的三维构效关系研究J. 药学学报, 1999, 34(2): 114-118.
引用本文: 彭晖, 杨纯正, 梁巍, 齐静, 黄牛, 郭宗儒. 吩噻嗪类化合物抑制肿瘤细胞多药耐药及蛋白激酶C活性的三维构效关系研究J. 药学学报, 1999, 34(2): 114-118.
Peng Hui, Yang Chunzheng, Liang Wei Qi Jing, Huang Niu , Guo Zongru, . STRUCTURE-ACTIVITY RELATIONSHIP OF PHENOTHIAZINES FOR INHIBITION OF PROTEIN KINASE C AND REVERSAL OF MULTIDRUG RESISTANCEJ. Acta Pharmaceutica Sinica, 1999, 34(2): 114-118.
Citation: Peng Hui, Yang Chunzheng, Liang Wei Qi Jing, Huang Niu , Guo Zongru, . STRUCTURE-ACTIVITY RELATIONSHIP OF PHENOTHIAZINES FOR INHIBITION OF PROTEIN KINASE C AND REVERSAL OF MULTIDRUG RESISTANCEJ. Acta Pharmaceutica Sinica, 1999, 34(2): 114-118.

吩噻嗪类化合物抑制肿瘤细胞多药耐药及蛋白激酶C活性的三维构效关系研究

STRUCTURE-ACTIVITY RELATIONSHIP OF PHENOTHIAZINES FOR INHIBITION OF PROTEIN KINASE C AND REVERSAL OF MULTIDRUG RESISTANCE

  • 摘要: 目的:利用本室诱导建立的耐药细胞株K562/A02,研究在体外条件下吩噻嗪类衍生物(PTZs)逆转多药耐药(MDR)活性的构效关系。方法与结果:利用已知PKC Cys 2功能区晶体结构,结合计算化学和分子图形学手段对PKC抑制剂与PKC蛋白分子间可能的相互作用模式进行探讨。结果表明,2位取代各种基团逆转MDR作用强度依次为:COC3H7>CF3>COCH3>H。边链哌嗪环4′-位取代基作用强度为:CH3>COOC2H5>C2H4OH。结论:选出代表性化合物测定对鼠脑的抑制活性,初步三维构效关系研究表明,PTZs抑制PKC活性确实与特定的立体结构特征有关。本研究为进一步探索PTZs,PKC和MDR三者间的内在机制和设计有效PKC抑制剂或多药耐药逆转剂提供了新的途径。

     

    Abstract: AIM: To study the structure-activity relationship of phenothiazines(PTZs) for inhibition of protein kinase C (PKC) and reversal of multidrug resistance (MDR) in vitro. METHODS and RESULTS: The possible binding model of PTZs to PKC based upon the X-ray structure of PMA(phorbol myristic acetate) in complex with PKC Cys 2 with DOCK program was explored. The results showed that the order of potency of reversal effect of PTZs on MDR is as follows: 2-COC3H7>2-CF3>2-COCH3>H. The type of piperazinyl substitution also significantly affected potency against MDR. The result showed the order: CH3>COOC2H5>C2H4OH. CONCLUSION: Some derivatives of PTZ was tested for inhibition of PKC. The observation indicates that PTZs inhibit PKC in a manner related to specific structural feature. Our molecular-modeling study suggests preliminarily how these PTZs bind to PKC and provide a structural basis for the design of high affinity PKC-modulator. Our structure-activity studies offer a way to understand which molecular structure affects activity, and this information may be used in the rational design of more effective drugs.

     

/

返回文章
返回